To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RESTTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
242 supporting clones for gene REST back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_005612.4   .a 1 to 7333 1 to 7333 exact RefSeq,   7333/7333
(100 %)
0 diff
(100 %id)
BF727186 eye, lens .a 34 to 464 1 to 431       431/431
(100 %)
2 diff
(99.6 %id)
CD676169 eye, lens .a 34 to 637 1 to 604   tiling clone,   604/604
(100 %)
1 diff
(99.9 %id)
DR006314 Prostate .a 56 to 782 1 to 727       727/727
(100 %)
6 diff
(99.2 %id)
BC038985 Uterus, leiomyosarcoma .a 83 to 1709 12 to 1638   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1627/1628
(99 %)
5 diff
(99.7 %id)
BQ050976 leiomyosarcoma, uterus .a 84 to 710 1 to 633   available from MGC,   633/774
(81 %)
25 diff
(96.8 %id)
U13879   .a 101 to 2140 1 to 2040       2040/2043
(99 %)
7 diff
(99.7 %id)
CR977496 T-Lymphocytes .a 108 to 907 1 to 800       800/800
(100 %)
1 diff
(99.9 %id)
U22680   .a 196 to 6180 14 to 5990   tiling clone,   5977/6635
(90 %)
22 diff
(99.7 %id)
CR975726 T-Lymphocytes .a 276 to 1041 1 to 766       766/766
(100 %)
0 diff
(100 %id)
AA094832   .a 284 to 534 1 to 247       247/247
(100 %)
12 diff
(95.2 %id)
TI_1971555167   .a 321 to 1500 46 to 1211       1166/1300
(89 %)
29 diff
(97.8 %id)
TI_1752768608   .a 321 to 1436 44 to 1153   AAA   1110/1259
(88 %)
18 diff
(98.6 %id)
BC132859 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .a 325 to 3731 1 to 3407       3407/3407
(100 %)
2 diff
(100.0 %id)
BC136491 Testicle, PCR rescued clones .a 325 to 3731 1 to 3407   tiling clone,   3407/3407
(100 %)
0 diff
(100 %id)
ES313559 beard hair, skin .a 326 to 801 1 to 470       470/470
(100 %)
8 diff
(98.3 %id)
BF216473 brain, glioblastoma .a 534 to 1044 126 to 639       514/893
(57 %)
25 diff
(97.3 %id)
AW390236 stomach .a 570 to 1070 1 to 505       505/505
(100 %)
18 diff
(96.5 %id)
AA248721   .a 592 to 865 1 to 279       279/280
(99 %)
6 diff
(97.9 %id)
CB131624 Liver .a 611 to 1135 1 to 525       525/525
(100 %)
0 diff
(100 %id)
CB135540 Liver .a 611 to 1054 1 to 444       444/444
(100 %)
0 diff
(100 %id)
BE814143 breast_normal .a 659 to 1081 433 to 13       421/433
(97 %)
0 diff
(100 %id)
CR987937 T-Lymphocytes .a 843 to 1709 1 to 864   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 864/865
(99 %)
6 diff
(99.4 %id)
CN344603 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 845 to 1355 1 to 511       511/511
(100 %)
0 diff
(100 %id)
BF883880 lung_tumor .a 903 to 1429 526 to 4     Submitted on the opposite strand 523/526
(99 %)
5 diff
(99.1 %id)
TI_1971555097   .a 908 to 2120 1 to 1192       1192/1314
(90 %)
35 diff
(97.4 %id)
TI_1971559091   .a 921 to 1981 1078 to 19       1060/1272
(83 %)
57 diff
(95.6 %id)
BX283975 bladder, carcinoma, cell line .a 1012 to 1397 1 to 386       386/386
(100 %)
0 diff
(100 %id)
BF028361 bladder, carcinoma, cell line .a 1031 to 1737 1 to 707       707/748
(94 %)
16 diff
(97.9 %id)
AA489735 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1101 to 1328 1 to 228       228/228
(100 %)
2 diff
(99.2 %id)
R31356 placenta .a 1135 to 1530 1 to 404       404/404
(100 %)
10 diff
(97.6 %id)
H82188 melanocyte .a 1175 to 1307 1 to 133       133/133
(100 %)
0 diff
(100 %id)
AI917795 pooled germ cell tumors .a 1179 to 1673 495 to 1       495/495
(100 %)
1 diff
(99.8 %id)
TI_154000819   .a 1183 to 1694 585 to 75   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 511/586
(87 %)
0 diff
(100 %id)
BF029851 hypernephroma, Kidney .a 1197 to 1820 1 to 626       626/626
(100 %)
11 diff
(98.3 %id)
CA432947 mixed .a 1203 to 1694 493 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 491/493
(99 %)
0 diff
(100 %id)
DW466992 Liver .a 1214 to 1547 16 to 349       334/349
(95 %)
6 diff
(98.3 %id)
DW412741 Liver .a 1242 to 1554 11 to 323       313/323
(96 %)
7 diff
(97.9 %id)
CD698059 normal nasopharynx .a 1251 to 1734 33 to 517       485/517
(93 %)
7 diff
(98.7 %id)
BX489795   .a 1257 to 1871 1 to 615       615/615
(100 %)
2 diff
(99.7 %id)
AI740830 pooled .a 1260 to 1968 709 to 1       709/709
(100 %)
0 diff
(100 %id)
AI628218 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1326 to 1969 643 to 1       643/643
(100 %)
10 diff
(98.5 %id)
BE466099 pooled germ cell tumors .a 1340 to 1969 629 to 1       629/634
(99 %)
2 diff
(99.7 %id)
H82083 melanocyte .a 1349 to 1700 356 to 1       356/356
(100 %)
7 diff
(98.1 %id)
AI985495 Kidney .a 1353 to 1965 607 to 1       607/607
(100 %)
13 diff
(97.9 %id)
TI_1752769098   .a 1379 to 2523 12 to 1145       1134/1250
(90 %)
6 diff
(99.6 %id)
DW422319 Liver .a 1405 to 1683 17 to 295       279/295
(94 %)
6 diff
(98.0 %id)
DW438380 Liver .a 1405 to 1631 17 to 246       230/246
(93 %)
6 diff
(97.6 %id)
BE009241 breast_normal .a 1429 to 1731 8 to 310       303/310
(97 %)
6 diff
(98.1 %id)
AA932318 pooled germ cell tumors .a 1446 to 1969 524 to 1       524/524
(100 %)
18 diff
(96.6 %id)
AA748332 germinal center B cell .a 1502 to 2079 580 to 3       578/585
(98 %)
0 diff
(100 %id)
AW994718 breast_normal .a 1548 to 1903 1 to 356       356/356
(100 %)
2 diff
(99.5 %id)
R32858 placenta .a 1653 to 1969 322 to 2       321/322
(99 %)
0 diff
(100 %id)
AA766208 germinal center B cell .a 1715 to 2104 394 to 5       390/394
(98 %)
0 diff
(100 %id)
DB093352 testis .a 1733 to 2289 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB093404 testis .a 1733 to 2295 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
AW148454 Kidney, renal cell tumor .a 1758 to 2072 312 to 1       312/312
(100 %)
8 diff
(97.5 %id)
AI073979 B-cell, chronic lymphotic leukemia .a 1765 to 2237 1 to 474     Submitted on the opposite strand 474/474
(100 %)
1 diff
(99.8 %id)
BX492006   .a 1810 to 2326 1 to 517       517/517
(100 %)
1 diff
(99.9 %id)
FN082249 breast carcinoma .a 1874 to 1991 1 to 118       118/119
(99 %)
1 diff
(99.2 %id)
BF747073 breast .a 1941 to 2189 152 to 400       249/400
(62 %)
6 diff
(98.5 %id)
TI_154110600   .a 1946 to 2815 899 to 38   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 862/1008
(85 %)
0 diff
(100 %id)
TI_1971559089   .a 1978 to 3016 1038 to 9       1030/1228
(83 %)
0 diff
(100 %id)
Z20493   .a 2038 to 2234 199 to 3       197/199
(98 %)
0 diff
(100 %id)
BQ182959 Chondrosarcoma, Left Pubic Bone .a 2060 to 2815 757 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 756/760
(99 %)
0 diff
(100 %id)
TI_1752771550   .a 2122 to 3277 10 to 1152       1143/1282
(89 %)
6 diff
(99.6 %id)
AI978576 pooled germ cell tumors .a 2181 to 2797 618 to 1       618/618
(100 %)
12 diff
(98.1 %id)
DA889157   .a 2203 to 2769 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
BE139076 lung, two pooled squamous cell carcinomas .a 2217 to 2797 582 to 1       582/582
(100 %)
8 diff
(98.7 %id)
AW511391 pooled germ cell tumors .a 2245 to 2797 553 to 1       553/553
(100 %)
1 diff
(99.9 %id)
AI969754 pooled germ cell tumors .a 2283 to 2797 522 to 1       522/522
(100 %)
18 diff
(96.6 %id)
AW444866   .a 2291 to 2814 522 to 1       522/522
(100 %)
0 diff
(100 %id)
BE466700 pooled germ cell tumors .a 2344 to 2797 454 to 1       454/454
(100 %)
0 diff
(100 %id)
AW449489   .a 2357 to 2814 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AW297078   .a 2383 to 2814 432 to 1       432/433
(99 %)
0 diff
(100 %id)
T82966 liver and spleen .a 2487 to 2794 1 to 317       317/324
(97 %)
17 diff
(94.8 %id)
R07110 liver and spleen .a 2487 to 2797 1 to 313   fully sequenced,   313/313
(100 %)
7 diff
(97.8 %id)
R07111 liver and spleen .a 2604 to 2787 183 to 1   fully sequenced,   183/183
(100 %)
2 diff
(99.0 %id)
TI_1752768610   .a 2690 to 3734 1107 to 67       1041/1267
(82 %)
0 diff
(100 %id)
BI021405 marrow .a 2963 to 3412 450 to 1       450/450
(100 %)
0 diff
(100 %id)
TI_1752769100   .a 3020 to 3734 11 to 725       715/1259
(56 %)
2 diff
(99.9 %id)
BG010501 placenta_normal .a 3023 to 3414 24 to 414       391/414
(94 %)
6 diff
(98.6 %id)
AL044868 testis .a 3097 to 3656 1 to 560       560/560
(100 %)
0 diff
(100 %id)
AI671959 Kidney .a 3199 to 3476 278 to 1       278/278
(100 %)
0 diff
(100 %id)
BQ311634 breast_normal .a 3328 to 3607 281 to 1       281/512
(54 %)
1 diff
(99.9 %id)
BX497741 Liver .a 3432 to 3828 1 to 397       397/397
(100 %)
7 diff
(98.3 %id)
DA396159 thalamus .a 3464 to 4009 2 to 548   capped   547/547
(100 %)
3 diff
(99.5 %id)
DA186722 amygdala .a 3613 to 4179 2 to 570   tiling clone, capped   569/569
(100 %)
1 diff
(99.9 %id)
DA311389 hippocampus .a 3654 to 4224 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
DA452560 tongue, tumor tissue .a 3706 to 4275 2 to 573   tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
BX470438   .a 3983 to 4604 1 to 623   tiling clone,   623/623
(100 %)
1 diff
(99.9 %id)
DA494257 brain .a 4022 to 4359 2 to 338   capped   337/337
(100 %)
2 diff
(99.5 %id)
DB141774 thymus .a 4038 to 4315 2 to 279   capped   278/278
(100 %)
2 diff
(99.3 %id)
AW502881 lymph .a 4115 to 4514 17 to 418       402/418
(96 %)
6 diff
(98.6 %id)
TI_154158517   .a 4115 to 4702 89 to 676       588/610
(96 %)
36 diff
(94.1 %id)
CN422527 embryonic stem cells, DMSO-treated H9 cellline .a 4344 to 5144 1 to 801       801/801
(100 %)
13 diff
(98.4 %id)
AL691821   .a 4426 to 4864 1 to 439       439/443
(99 %)
2 diff
(99.6 %id)
DA393867 thalamus .a 4444 to 5036 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
DB136843 thymus .a 4530 to 5008 2 to 480   capped   479/479
(100 %)
1 diff
(99.8 %id)
DA887642   .a 4589 to 5133 2 to 546   tiling clone, capped   545/545
(100 %)
0 diff
(100 %id)
BQ421628 embryonal carcinoma, cell line, testis .a 4660 to 5302 1 to 651       651/961
(67 %)
20 diff
(98.0 %id)
AA905490 pooled .a 4712 to 5221 1 to 512     Submitted on the opposite strand 512/512
(100 %)
3 diff
(99.5 %id)
CN422528 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4781 to 5320 1 to 540       540/540
(100 %)
0 diff
(100 %id)
CA393464 eye, RPE/choroid .a 4824 to 5297 1 to 474       474/474
(100 %)
0 diff
(100 %id)
AU134037 ovary, tumor tissue .a 4846 to 5582 2 to 738   tiling clone, capped   737/744
(99 %)
1 diff
(99.9 %id)
W74281 Pancreas, pancreatic islet .a 4879 to 5242 1 to 364       364/364
(100 %)
0 diff
(100 %id)
BF751237 breast_normal .a 4931 to 5321 121 to 511       391/520
(75 %)
6 diff
(98.9 %id)
AA300694 testis .a 5030 to 5341 1 to 312       312/312
(100 %)
0 diff
(100 %id)
AW389987 stomach .a 5054 to 5467 430 to 18       413/430
(96 %)
0 diff
(100 %id)
BE002639 breast_normal .a 5107 to 5582 28 to 503       476/503
(94 %)
6 diff
(98.9 %id)
DB293893   .a 5113 to 5461 2 to 349   capped   348/667
(52 %)
2 diff
(99.8 %id)
CD655471 Embryonic Stem cells .a 5132 to 5937 11 to 809       799/810
(98 %)
17 diff
(98.0 %id)
BX483064   .a 5157 to 5811 1 to 655       655/655
(100 %)
1 diff
(99.9 %id)
DA703315   .a 5198 to 5758 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DB168701 kidney, tumor tissue .a 5212 to 5801 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
BM551017 duodenal adenocarcinoma, cell line, small intestine .a 5232 to 6260 1 to 1050   tiling clone,   1050/1125
(93 %)
61 diff
(94.6 %id)
DA639098 Liver .a 5250 to 5812 2 to 564   capped   563/566
(99 %)
2 diff
(99.7 %id)
CN422529 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 5265 to 5803 12 to 549       538/549
(97 %)
6 diff
(99.0 %id)
CB998591 Blood vessels - aorta, basilar and artery .a 5284 to 5829 1 to 557       557/821
(67 %)
20 diff
(97.6 %id)
AL041958 testis .a 5343 to 5813 1 to 471       471/475
(99 %)
1 diff
(99.8 %id)
AI911224 pooled .a 5356 to 5763 1 to 407     Submitted on the opposite strand 407/407
(100 %)
4 diff
(99.1 %id)
BE856589 pooled .a 5356 to 5632 1 to 277     Submitted on the opposite strand 277/277
(100 %)
0 diff
(100 %id)
AI022988 parathyroid gland, parathyroid tumor .a 5360 to 5762 1 to 403     Submitted on the opposite strand 403/403
(100 %)
0 diff
(100 %id)
AA724765 pooled .a 5362 to 5757 1 to 398     Submitted on the opposite strand 398/398
(100 %)
3 diff
(99.3 %id)
AA094710   .a 5411 to 5672 1 to 262       262/277
(94 %)
7 diff
(97.5 %id)
CN422526 embryonic stem cells, DMSO-treated H9 cellline .a 5414 to 5798 1 to 385       385/385
(100 %)
1 diff
(99.8 %id)
DA600805   .a 5449 to 6009 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CD102053 Pooled-Skin .a 5494 to 6237 1 to 757   tiling clone,   757/764
(99 %)
27 diff
(96.5 %id)
BP418817 small intestine .a 5519 to 6042 1 to 524     Submitted on the opposite strand 524/524
(100 %)
3 diff
(99.5 %id)
AI631845 Kidney .a 5534 to 6114 581 to 1   tiling clone,   581/581
(100 %)
0 diff
(100 %id)
AA300639 testis .a 5563 to 5696 1 to 134       134/134
(100 %)
1 diff
(99.3 %id)
AU155153 ovary, tumor tissue .a 6770 to 7332 562 to 1   tiling clone,   562/562
(100 %)
14 diff
(97.6 %id)
U22314   .b 1 to 3326 40 to 3365 P633L tiling clone,   3326/3365
(98 %)
7 diff
(99.8 %id)
BQ880428 dorsal root ganglia .c 1 to 499 1 to 504   tiling clone,   504/1260
(40 %)
21 diff
(98.4 %id)
AA305974   .c 148 to 660 1 to 511   tiling clone,   511/511
(100 %)
2 diff
(99.7 %id)
NM_001193508.1   .c 148 to 7269 1 to 7122 exact RefSeq,   7122/7122
(100 %)
0 diff
(100 %id)
AB209750 brain .c 197 to 3732 1 to 3536 exact tiling clone,   3536/3536
(100 %)
0 diff
(100 %id)
BG537176 lung .c 245 to 851 1 to 608   available from MGC,   608/609
(99 %)
7 diff
(98.9 %id)
BC017822 lung .c 246 to 1645 1 to 1400   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1400/1420
(98 %)
3 diff
(99.8 %id)
U13877   .d-u 1 to 1343 2 to 1342 V298L tiling clone,   1342/1345
(99 %)
6 diff
(99.6 %id)
AI032985 liver and spleen .d-u 1258 to 1544 287 to 1   tiling clone,   287/287
(100 %)
0 diff
(100 %id)
GD152962   .d-u 1459 to 1554 1 to 96   tiling clone,   96/101
(95 %)
5 diff
(95.1 %id)
AF228045 lung .e 1 to 578 1 to 578 exact tiling clone,   578/578
(100 %)
1 diff
(99.9 %id)
AW614539 Kidney .f-u 1 to 541 545 to -3 exact tiling clone,   545/545
(100 %)
0 diff
(100 %id)
AU134528 ovary, tumor tissue .f-u 1 to 682 2 to 684 exact capped   683/685
(99 %)
6 diff
(99.2 %id)
BF214609 bone marrow, from acute myelogenous leukemia .f-u 38 to 677 1 to 640 F4S N5K H7M Y9T I10L ...     640/845
(75 %)
23 diff
(97.3 %id)
BU569264 testis .f-u 90 to 885 1 to 797 exact     797/801
(99 %)
6 diff
(99.3 %id)
AW630777 2 pooled high-grade transitional celltumors, genitourinary tract .f-u 114 to 521 10 to 417 exact     408/417
(97 %)
6 diff
(98.6 %id)
BU934891 mixed (pool of 40 RNAs) .f-u 168 to 940 1 to 776       776/818
(94 %)
6 diff
(99.3 %id)
CN422525 embryonic stem cells, DMSO-treated H9 cellline .f-u 212 to 702 1 to 491       491/491
(100 %)
6 diff
(98.8 %id)
TI_57200465   .f-u 212 to 939 55 to 779       725/779
(93 %)
11 diff
(98.6 %id)
BI821316 pooled brain, lung, testis .f-u 226 to 939 1 to 711       711/711
(100 %)
9 diff
(98.8 %id)
BG992552 head_neck .f-u 303 to 851 550 to 3       548/550
(99 %)
0 diff
(100 %id)
BE439932 Trabecular meshwork .f-u 325 to 939 1 to 614   tiling clone,   614/614
(100 %)
1 diff
(99.9 %id)
BG497814 adenocarcinoma, Prostate .f-u 491 to 1103 1 to 620       620/635
(97 %)
45 diff
(93.0 %id)
AA361305   .f-u 514 to 752 1 to 239       239/239
(100 %)
2 diff
(99.2 %id)
AW880946 ovary .f-u 685 to 1080 396 to 1       396/396
(100 %)
7 diff
(98.3 %id)
BG926324 cartilage .f-u 713 to 1227 97 to 613       517/541
(95 %)
3 diff
(99.5 %id)
BF677795 Prostate .f-u 730 to 871 559 to 712       668/788
(84 %)
37 diff
(95.4 %id)
R69696 placenta .f-u 744 to 961 9 to 226       218/226
(96 %)
6 diff
(97.4 %id)
CA396786 eye, RPE/choroid .f-u 781 to 1311 1 to 531   tiling clone,   531/531
(100 %)
0 diff
(100 %id)
TI_149315411   .f-u 889 to 1759 952 to 86   AAA   867/971
(89 %)
12 diff
(98.8 %id)
TI_149297087   .f-u 906 to 1759 937 to 92   AAA   846/938
(90 %)
14 diff
(98.6 %id)
BQ723235 sympathetic trunk .f-u 919 to 1759 23 to 868       846/908
(93 %)
18 diff
(98.1 %id)
AV739647 cord Blood .f-u 926 to 1346 433 to 27     Submitted on the opposite strand 407/433
(93 %)
0 diff
(100 %id)
CN478828 Human Lung Epithelial cells, lung .f-u 926 to 1535 1 to 611     Submitted on the opposite strand 611/620
(98 %)
4 diff
(99.4 %id)
TI_151702497.
matches multiple genes
  .f-u 926 to 1745 70 to 880     Submitted on the opposite strand, also hits gene smoyvey 811/1034
(78 %)
49 diff
(95.3 %id)
AI807320 carcinoid, lung .f-u 934 to 1384 1 to 454     Submitted on the opposite strand 454/454
(100 %)
5 diff
(98.9 %id)
R68978 placenta .f-u 940 to 1254 1 to 317       317/415
(76 %)
3 diff
(99.3 %id)
AI693146 carcinoid, lung .f-u 941 to 1469 1 to 529     Submitted on the opposite strand 529/529
(100 %)
0 diff
(100 %id)
AU185637 skin .f-u 942 to 1518 1 to 579       579/579
(100 %)
9 diff
(98.5 %id)
CN369558 embryonic stem cells, DMSO-treated H9 cellline .f-u 968 to 1740 773 to 1     Submitted on the opposite strand 773/773
(100 %)
0 diff
(100 %id)
H04882 placenta .f-u 984 to 1221 1 to 245       245/253
(96 %)
16 diff
(93.7 %id)
BF691430 melanotic melanoma, high MDR, skin .f-u 987 to 1727 1 to 728       728/728
(100 %)
33 diff
(95.5 %id)
CA312250 Human Lung Epithelial cells, lung .f-u 1054 to 1759 724 to 19   AAA   706/706
(100 %)
0 diff
(100 %id)
BM982215 lung, Primary Lung Cystic Fibrosis EpithelialCells .f-u 1060 to 1759 718 to 19   AAA   700/700
(100 %)
0 diff
(100 %id)
BQ045299 lung, Primary Lung Cystic Fibrosis EpithelialCells .f-u 1065 to 1759 713 to 19   AAA   695/695
(100 %)
0 diff
(100 %id)
CN290142 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f-u 1066 to 1560 1 to 495       495/495
(100 %)
3 diff
(99.4 %id)
BF845131 head_neck .f-u 1099 to 1302 1 to 204       204/210
(97 %)
2 diff
(99.1 %id)
TI_154136486   .f-u 1103 to 1759 721 to 61   AAA   661/1095
(60 %)
24 diff
(97.9 %id)
AW958137   .f-u 1106 to 1751 647 to 1     Submitted on the opposite strand 647/652
(99 %)
12 diff
(98.2 %id)
BE150979 head_neck .f-u 1109 to 1498 12 to 404       393/412
(95 %)
14 diff
(96.7 %id)
BQ016417 lung, Metastatic Chondrosarcoma .f-u 1114 to 1759 666 to 19   AAA   648/651
(99 %)
7 diff
(99.0 %id)
BQ422139 embryonal carcinoma, cell line, testis .f-u 1142 to 1759 1 to 618   AAA   618/618
(100 %)
0 diff
(100 %id)
N55144 multiple sclerosis lesions .f-u 1149 to 1339 1 to 191   fully sequenced,   191/191
(100 %)
3 diff
(98.5 %id)
DN914268   .f-u 1155 to 1753 599 to 1       599/599
(100 %)
2 diff
(99.7 %id)
TI_158434982   .f-u 1158 to 1761 694 to 90   AAA   605/963
(62 %)
13 diff
(98.7 %id)
TI_149272835   .f-u 1175 to 1760 701 to 115       587/1047
(56 %)
0 diff
(100 %id)
TI_149277238   .f-u 1175 to 1752 662 to 86   AAA   577/725
(79 %)
10 diff
(98.7 %id)
BM968086 lung, Primary Lung Epithelial Cells .f-u 1175 to 1752 595 to 19   AAA   577/589
(97 %)
10 diff
(98.4 %id)
AW965500   .f-u 1179 to 1751 578 to 1     Submitted on the opposite strand 578/581
(99 %)
25 diff
(95.7 %id)
AW978767   .f-u 1190 to 1691 506 to 1     Submitted on the opposite strand 506/524
(96 %)
21 diff
(96.0 %id)
TI_149280380   .f-u 1194 to 1759 643 to 78   AAA   566/708
(79 %)
4 diff
(99.5 %id)
AW195605 pooled .f-u 1202 to 1760 568 to 9       560/568
(98 %)
0 diff
(100 %id)
AU155480 ovary, tumor tissue .f-u 1207 to 1762 554 to 1   tiling clone,   554/554
(100 %)
10 diff
(98.2 %id)
CB047626 Kidney .f-u 1210 to 1387 7 to 187       181/187
(96 %)
6 diff
(96.8 %id)
BM661760.
matches multiple genes
eye, Retina Foveal and Macular .f-u 1210 to 1760 568 to 18     also hits gene veejyby 551/571
(96 %)
0 diff
(100 %id)
AW075561 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .f-u 1215 to 1760 546 to 3       544/546
(99 %)
0 diff
(100 %id)
AW207586   .f-u 1228 to 1759 549 to 18   AAA   532/532
(100 %)
0 diff
(100 %id)
AI758241 Kidney .f-u 1241 to 1756 518 to 3       516/518
(99 %)
0 diff
(100 %id)
AA993676   .f-u 1248 to 1762 520 to 7       514/520
(98 %)
0 diff
(100 %id)
BQ024616 placenta .f-u 1251 to 1759 527 to 19   AAA   509/509
(100 %)
1 diff
(99.9 %id)
BF434811 Kidney .f-u 1254 to 1760 507 to 1       507/507
(100 %)
1 diff
(99.9 %id)
BE551531 pooled germ cell tumors .f-u 1262 to 1759 516 to 19   AAA   498/498
(100 %)
2 diff
(99.6 %id)
BQ022696 placenta .f-u 1262 to 1759 516 to 19   AAA   498/498
(100 %)
4 diff
(99.2 %id)
AI799473 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f-u 1268 to 1760 493 to 1       493/493
(100 %)
1 diff
(99.8 %id)
AI031659 parathyroid gland, parathyroid tumor .f-u 1270 to 1760 497 to 7       491/497
(98 %)
0 diff
(100 %id)
AW068887 bone marrow stroma .f-u 1277 to 1756 502 to 23       480/502
(95 %)
0 diff
(100 %id)
AA961774 pooled germ cell tumors .f-u 1288 to 1759 470 to 1       470/474
(99 %)
2 diff
(99.6 %id)
AI419921 pooled .f-u 1290 to 1760 477 to 7       471/477
(98 %)
0 diff
(100 %id)
AI355364 lung .f-u 1293 to 1760 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
AA598664   .f-u 1320 to 1759 439 to 1       439/439
(100 %)
1 diff
(99.8 %id)
AA603695 germ cell tumor .f-u 1325 to 1759 432 to 1       432/432
(100 %)
4 diff
(99.1 %id)
AW468023 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .f-u 1325 to 1759 435 to 1       435/435
(100 %)
0 diff
(100 %id)
AV682285 hepatocellular carcinoma .f-u 1326 to 1759 20 to 453   AAA   434/453
(95 %)
6 diff
(98.7 %id)
AW057857 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1327 to 1759 433 to 1       433/433
(100 %)
0 diff
(100 %id)
AW665998 pooled .f-u 1327 to 1760 439 to 6       434/439
(98 %)
0 diff
(100 %id)
N50786 multiple sclerosis lesions .f-u 1337 to 1759 440 to 12   fully sequenced, AAA   429/429
(100 %)
10 diff
(97.7 %id)
AI510700 aorta .f-u 1338 to 1752 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AI190742   .f-u 1339 to 1759 436 to 16   AAA   421/421
(100 %)
1 diff
(99.8 %id)
AW627549 2 pooled high-grade transitional celltumors, genitourinary tract .f-u 1345 to 1759 426 to 12   AAA   415/415
(100 %)
0 diff
(100 %id)
AW451406   .f-u 1353 to 1759 424 to 18   AAA   407/410
(99 %)
3 diff
(99.3 %id)
R69607 placenta .f-u 1370 to 1745 392 to 1       392/393
(99 %)
23 diff
(94.2 %id)
EB643228   .f-u 1377 to 1648 287 to 16       272/308
(88 %)
0 diff
(100 %id)
AW594696 pooled germ cell tumors .f-u 1377 to 1759 391 to 1       391/391
(100 %)
8 diff
(98.0 %id)
BQ021884 placenta .f-u 1379 to 1759 398 to 18   AAA   381/381
(100 %)
1 diff
(99.8 %id)
BF593134 Kidney .f-u 1390 to 1759 370 to 1       370/370
(100 %)
2 diff
(99.5 %id)
AA766363 germinal center B cell .f-u 1391 to 1760 381 to 11       371/381
(97 %)
0 diff
(100 %id)
AA737532 germinal center B cell .f-u 1398 to 1759 371 to 11   AAA   361/361
(100 %)
1 diff
(99.8 %id)
BE535697 cervix .f-u 1401 to 1760 1 to 357       357/357
(100 %)
4 diff
(98.9 %id)
CN369557 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f-u 1438 to 1760 8 to 330       323/332
(97 %)
1 diff
(99.7 %id)
BF194841 Kidney .f-u 1444 to 1758 315 to 1       315/315
(100 %)
5 diff
(98.5 %id)
AI124003 uterus .f-u 1468 to 1759 302 to 11   AAA   292/292
(100 %)
0 diff
(100 %id)
H04784 placenta .f-u 1478 to 1746 286 to 17       270/295
(91 %)
0 diff
(100 %id)
AI445187 colon, moderately-differentiated adenocarcinoma .f-u 1488 to 1760 281 to 9       273/281
(97 %)
0 diff
(100 %id)
AW102731 pooled .f-u 1489 to 1759 271 to 1       271/271
(100 %)
0 diff
(100 %id)
AI122873 uterus .f-u 1513 to 1762 250 to 1       250/250
(100 %)
0 diff
(100 %id)
AI253794 Prostate .f-u 1521 to 1762 242 to 1       242/242
(100 %)
0 diff
(100 %id)
AA897328 pooled .f-u 1539 to 1760 230 to 9       222/230
(96 %)
0 diff
(100 %id)
AI540516 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f-u 1552 to 1759 208 to 1       208/208
(100 %)
2 diff
(99.1 %id)
AA598571   .f-u 1556 to 1759 204 to 1       204/204
(100 %)
0 diff
(100 %id)
D19777   .f-u 1571 to 1760 1 to 190     Submitted on the opposite strand 190/192
(98 %)
5 diff
(97.4 %id)
CB047625 Kidney .f-u 1579 to 1760 231 to 49   AAA   183/183
(100 %)
16 diff
(91.3 %id)
AA334830   .f-u 1585 to 1759 179 to 1     Submitted on the opposite strand 179/184
(97 %)
7 diff
(96.2 %id)
GD147063   .f-u 1641 to 1759 1 to 119   AAA   119/119
(100 %)
1 diff
(99.2 %id)
CD692539 normal nasopharynx Gene REST, variant not shown         This clone was ignored    
AV656588 corresponding non cancerous liver tissue Gene REST, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB313393 tongue, tumor tissue Gene REST, variant not shown         This clone was ignored    
DA435953 tongue, tumor tissue Gene REST, variant not shown       capped This clone was ignored    
AI872294 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus Gene REST, variant not shown         This clone was ignored    
BG285188 adenocarcinoma, cell line, Prostate Gene REST, variant not shown       AAA This clone was ignored    
BG540672 lung Gene REST, variant not shown              
BU520899 leiomyosarcoma, uterus Gene REST, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e, .f-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI